A Cutaneous Lupus Erythematosus-Like Eruption Induced by Hydroxyurea.
Hydroxyurea is a medication with many well-described cutaneous side effects, notably the dermatomyositis-like eruption known as hydroxyurea dermopathy. Although systemic lupus erythematosus has been reported with hydroxyurea use, cutaneous lupus has not. We report a novel case of chronic cutaneous lupus induced by hydroxyurea and propose that this is a side effect that is distinct from hydroxyurea dermopathy.
Division of Dermatology, Department of Pediatrics, Nationwide Children's Hospital, Ohio State University Wexner Medical Center, Columbus, Ohio.
Daniel A
DA
Yanes
Division of Dermatology, Department of Pediatrics, Nationwide Children's Hospital, Ohio State University Wexner Medical Center, Columbus, Ohio.
Joy L
JL
Mosser-Goldfarb
D000293:Adolescent; D003875:Drug Eruptions / Q000175:diagnosis / Q000209:etiology*; D005260:Female; D006801:Humans; D006918:Hydroxyurea / Q000009:adverse effects*; D008178:Lupus Erythematosus, Cutaneous / Q000139:chemically induced* / Q000175:diagnosis; D019384:Nucleic Acid Synthesis Inhibitors / Q000009:adverse effects*; D012867:Skin / Q000473:pathology*
D019384:Nucleic Acid Synthesis Inhibitors; D006918:Hydroxyurea